Mgo One Seven LLC Novo Nordisk A S Transaction History

Mgo One Seven LLC

$2.26 Billion
Q3 2024

A detailed history of Mgo One Seven LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Mgo One Seven LLC holds 17,653 shares of NVO stock, worth $1.86 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

17,653

Previous 19,799 10.84%

Holding current value

$1.86 Million

Previous $2.83 Million 25.65%

% of portfolio

0.09%

Previous 0.14%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$119.07 - $145.42 $255,524 - $312,071	-2,146 Reduced 10.84%	17,653 $2.1 Million
Q2 2024 Aug 07, 2024	BUY	$122.71 - $146.91 $445,314 - $533,136	3,629 Added 22.44%	19,799 $2.83 Million
Q1 2024 May 14, 2024	SELL	$102.11 - $135.92 $149,080 - $198,443	-1,460 Reduced 8.28%	16,170 $2.08 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $52,668 - $63,270	600 Added 3.52%	17,630 $1.82 Million
Q3 2023 Nov 03, 2023	BUY	$90.94 - $199.54 $839,649 - $1.84 Million	9,233 Added 118.42%	17,030 $1.55 Million
Q2 2023 Aug 11, 2023	SELL	$155.98 - $172.65 $71,126 - $78,728	-456 Reduced 5.53%	7,797 $1.26 Million
Q1 2023 May 08, 2023	BUY	$132.34 - $159.14 $48,568 - $58,404	367 Added 4.65%	8,253 $1.31 Million
Q4 2022 Jan 25, 2023	BUY	$102.55 - $135.33 $7,691 - $10,149	75 Added 0.96%	7,886 $0
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $78,415 - $96,233	-823 Reduced 9.53%	7,811 $778,000
Q2 2022 Aug 10, 2022	SELL	$103.24 - $121.81 $472,632 - $557,646	-4,578 Reduced 34.65%	8,634 $962,000
Q1 2022 May 13, 2022	SELL	$93.1 - $112.54 $17,502 - $21,157	-188 Reduced 1.4%	13,212 $1.13 Million
Q4 2021 Feb 09, 2022	BUY	$95.88 - $117.08 $98,948 - $120,826	1,032 Added 8.34%	13,400 $1.16 Million
Q3 2021 Nov 09, 2021	BUY	$84.42 - $106.62 $93,537 - $118,134	1,108 Added 9.84%	12,368 $1.03 Million
Q2 2021 Jul 29, 2021	BUY	$67.66 - $84.76 $11,231 - $14,070	166 Added 1.5%	11,260 $690,000
Q1 2021 Apr 29, 2021	SELL	$67.06 - $75.82 $44,863 - $50,723	-669 Reduced 5.69%	11,094 $544,000
Q4 2020 Jan 22, 2021	BUY	$63.89 - $73.8 $191 - $221	3 Added 0.03%	11,763 $611,000
Q3 2020 Oct 30, 2020	SELL	$63.69 - $70.22 $11,782 - $12,990	-185 Reduced 1.55%	11,760 $607,000
Q2 2020 Aug 12, 2020	BUY	$58.54 - $67.94 $192,596 - $223,522	3,290 Added 38.01%	11,945 $585,000
Q1 2020 Apr 17, 2020	BUY	$49.46 - $64.78 $26,263 - $34,398	531 Added 6.54%	8,655 $521,000
Q4 2019 Jan 16, 2020	BUY	$49.86 - $58.26 $405,062 - $473,304	8,124 New	8,124 $470,000
Q1 2019 Apr 09, 2019	SELL	$46.36 - $52.63 $46,452 - $52,735	-1,002 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$41.54 - $47.25 $41,623 - $47,344	1,002 New	1,002 $46,000
Q3 2018 Oct 09, 2018	SELL	$46.76 - $51.24 $53,493 - $58,618	-1,144 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $33,943 - $40,698	-700 Reduced 37.96%	1,144 $56,000
Q4 2017 Feb 16, 2018	BUY	$47.53 - $53.73 $87,645 - $99,078	1,844	1,844 $99,000

Others Institutions Holding NVO

# of Institutions

1,948

Shares Held

320M

Call Options Held

5.22M

Put Options Held

6.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $238B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.

Account